| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/21/2001 | CN1284866A Oral pharmaceutical extended release dosage form |
| 02/21/2001 | CN1284378A Medicine for treating active-stage hepatitis B and its preparation |
| 02/21/2001 | CN1284377A Medicine for treating resting-stage hepatitis B and its prepartion |
| 02/21/2001 | CN1284376A Medicine for treating early-stage hepatocirrhosis and its preparation |
| 02/21/2001 | CN1284374A Hepatosis treating medicine powder and oral liquid |
| 02/21/2001 | CN1284372A 'Sanhuangqinbao' powder-medicine for chicken |
| 02/21/2001 | CN1284361A Cholecystitis capsule |
| 02/21/2001 | CN1284360A Tibeten medicine for treating hepatitis B and its preparation |
| 02/21/2001 | CN1284359A Women's tonic wine and its preparation |
| 02/21/2001 | CN1284358A Men's tonic wine and its preparation |
| 02/21/2001 | CN1284357A Yichun wine and its preparation |
| 02/21/2001 | CN1284354A Enteritis curing capsule |
| 02/21/2001 | CN1284349A Medicine pill for preventing and treating pathological seaility |
| 02/21/2001 | CN1284348A Liver protecting and pus drawing out ointment and its preparation |
| 02/21/2001 | CN1284342A Healthy manyprickle acanthopanax root oral liquid and its preparation |
| 02/21/2001 | CN1284333A Application of isopropylfuran in preparing hepatitis B virus resisting medicine |
| 02/21/2001 | CN1284331A Application of 5,3',5'-trihydroxy-methoxyl dihydroflavone in preparing medicine |
| 02/21/2001 | CN1062177C Anti-bacterium stomach curative capsules |
| 02/21/2001 | CN1062167C Hepatitis curing medicine |
| 02/21/2001 | CN1062157C Hepatitis B curing toxin-dissipating pill |
| 02/20/2001 | US6191271 Synthetic divalent sLex containing polylactosamines and methods for use |
| 02/20/2001 | US6191148 Omerazole process and compositions thereof |
| 02/20/2001 | US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes |
| 02/20/2001 | US6191139 Antidepressant |
| 02/20/2001 | US6191137 Pharmaceutical composition for oral administration |
| 02/20/2001 | US6191135 Respiratory system disorders, antiinflammatory agents; analgesics |
| 02/20/2001 | US6191130 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5T H1A receptors |
| 02/20/2001 | CA2192289C Substituted heterocyclic derivatives |
| 02/20/2001 | CA2060208C Wound healing |
| 02/20/2001 | CA2014569C Orally administered pharmaceutical composition for use in gastrointestinal washes, in particular for diagnostic use, or as cathartic laxative |
| 02/15/2001 | WO2001011089A1 Novel method for screening compound for preventing or treating liver cell injury caused by hepatitis c virus and compound obtained by this method |
| 02/15/2001 | WO2001011067A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011041A1 MONOMERIC PROTEIN OF THE TGF-β FAMILY |
| 02/15/2001 | WO2001011023A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | WO2001010893A2 Il-16 antagonists |
| 02/15/2001 | WO2001010866A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 02/15/2001 | WO2001010865A1 p38MAP KINASE INHIBITORS |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010833A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 02/15/2001 | WO2001010831A1 Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists |
| 02/15/2001 | WO2001010816A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/15/2001 | WO2001010453A2 Bifidobacteria capable of preventing diarrhea |
| 02/15/2001 | WO2001010431A2 Headache and colic relief composition with asafetida and method of use thereof |
| 02/15/2001 | WO2001010413A2 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 02/15/2001 | WO2001010401A1 Stable hydrogenated lupulone antibacterial oral compositions |
| 02/15/2001 | WO2001010392A2 Composition for restoring defects in calcified tissues |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | WO2000069900A3 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 02/15/2001 | WO2000066584B1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/15/2001 | WO2000066067A3 Ibd-associated microbial antigens and methods of using same |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000059483A3 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 02/15/2001 | WO2000057920A3 Method for expressing proteins |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000047243A3 Pancreatic ductal trophic factors, uses and composition related thereto |
| 02/15/2001 | WO2000047198A3 Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 02/15/2001 | DE19936719A1 Substituierte 1,5-Dihydropyrrol-2-on-Derivate Substituted 1,5-dihydropyrrol-2-one derivatives |
| 02/15/2001 | DE19936521A1 Substituierte Pyrrolidin-2,3,4-trion-3-oxim-Derivate Substituted pyrrolidine-2,3,4-trione-3-oxime Derivatives |
| 02/15/2001 | CA2403910A1 Headache and colic relief composition with asafetida and method of use thereof |
| 02/15/2001 | CA2382659A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | CA2381293A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | CA2381215A1 P38map kinase inhibitors |
| 02/15/2001 | CA2381033A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | CA2380973A1 Substituted pyrrolidine-2-3,4-trione 3-oxime derivatives which are active as nmda receptor antagonists |
| 02/15/2001 | CA2380759A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 02/15/2001 | CA2380678A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | CA2378587A1 Stable hydrogenated lupulone antibacterial oral compositions |
| 02/15/2001 | CA2377422A1 Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof |
| 02/14/2001 | EP1076066A1 Peptides for lowering blood glucose levels |
| 02/14/2001 | EP1076055A1 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| 02/14/2001 | EP1075519A2 Inhibitors of nf-kb activation |
| 02/14/2001 | EP1075489A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
| 02/14/2001 | EP1075476A1 Novel benzimidazoles and benzoxazoles |
| 02/14/2001 | EP1075475A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
| 02/14/2001 | EP1075472A1 Prodrugs of benzofuranylmethyl carbamate nk 1? antagonists |
| 02/14/2001 | EP1075467A1 Pyrazole derivatives as p-38 map kinase inhibitors |
| 02/14/2001 | EP1075280A2 Hemoglobine-haptoglobin complexes for targeted durg delivery |
| 02/14/2001 | EP1075273A2 Inhibiton of helicobacter pylori proliferation |
| 02/14/2001 | EP1075269A2 Anti-diarrheal and method for using the same |
| 02/14/2001 | EP1075262A1 Desmethylpantoprazole compositions and methods |
| 02/14/2001 | EP1075260A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis |
| 02/14/2001 | EP1075259A1 Novel fatty analogues for the treatment of diabetes |
| 02/14/2001 | EP1075258A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/14/2001 | CN1284078A Heterocycilc compounds for inhibition of gastric acid secretion, processes for their prepn. and pharmaceutical compsns thereof |
| 02/14/2001 | CN1284073A 5-(2-imidazolinylamino)-benzimidazole derivatives, their prepn. and their use as alpha-adrenoceptor agonists with inproved metabolic stability |
| 02/14/2001 | CN1283679A Health-care beer with kidney-nourishing and liver-protecting function and its brewing technology |
| 02/14/2001 | CN1283623A 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 02/14/2001 | CN1283506A Health-care composition and its preparing process |
| 02/14/2001 | CN1283505A Prescription and process for preparing medicine to treat toothche and odontopathy |
| 02/14/2001 | CN1283504A Medicinal prescription for treating hepatitides |
| 02/14/2001 | CN1283492A Tibetan medicine for treating hepatism and its preparing process |
| 02/14/2001 | CN1283491A Health tea |
| 02/14/2001 | CN1283486A Antidiarrheal |
| 02/14/2001 | CN1283469A Compound tablet 'Changning' and its preparing process |
| 02/14/2001 | CN1283468A Compound tablet 'Changning' and its preparing process |
| 02/14/2001 | CN1283455A Application of black fading hormone and black fading ligand in medicinal compsns for prevention and treatment of gastrointestional tract disease |